SLC22A1 Resists HBV by Activating JAK/STAT Pathway and Predicts Effect of Pegifnα-Based Therapy on CHB. Huiying Yu,Bin Li, Huili Guo,Lin Li, Xiaoquan Liu,Lili Wu, Na Gao,Qiyi Zhao,Xiuqing Pang,Zhiliang GaoThe Journal of infectious diseases(2025)引用 0|浏览7AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要